Published in Br J Dermatol on May 16, 2008
Risk of merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst (2015) 1.59
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol (2014) 1.32
Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions. Nucleic Acids Res (2009) 0.98
Protein oxidation and DNA repair inhibition by 6-thioguanine and UVA radiation. J Invest Dermatol (2013) 0.97
Immune effector cells produce lethal DNA damage in cells treated with a thiopurine. Cancer Res (2009) 0.91
DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation. Oncogene (2010) 0.90
The indirect antioxidant sulforaphane protects against thiopurine-mediated photooxidative stress. Carcinogenesis (2012) 0.89
Incidence of malignancy after living kidney transplantation: a multicenter study from iran. J Cancer (2012) 0.89
Guanine sulphinate is a major stable product of photochemical oxidation of DNA 6-thioguanine by UVA irradiation. Nucleic Acids Res (2009) 0.86
Crosslinking of DNA repair and replication proteins to DNA in cells treated with 6-thioguanine and UVA. Nucleic Acids Res (2011) 0.86
DNA repair inhibition by UVA photoactivated fluoroquinolones and vemurafenib. Nucleic Acids Res (2014) 0.82
PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients. Br J Cancer (2008) 0.81
Consensus Conference on Clinical Management of pediatric Atopic Dermatitis. Ital J Pediatr (2016) 0.78
Body image dissatisfaction in patients with inflammatory bowel disease. Inflamm Bowel Dis (2015) 0.77
Risk of non-melanoma skin cancer in autoimmune hepatitis. Dig Dis Sci (2010) 0.76
Protein oxidation, UVA and human DNA repair. DNA Repair (Amst) (2016) 0.75
Photosensitized UVA-Induced Cross-Linking between Human DNA Repair and Replication Proteins and DNA Revealed by Proteomic Analysis. J Proteome Res (2016) 0.75
Whole exome sequencing validates a preclinical mouse model for the prevention and treatment of cutaneous squamous cell carcinoma. Cancer Prev Res (Phila) (2016) 0.75
Induction of a DNA glycosylase for N-methylated purines is part of the adaptive response to alkylating agents. Nature (1982) 3.11
Inducible repair of O-alkylated DNA pyrimidines in Escherichia coli. EMBO J (1984) 2.77
Failed validation of a clinical decision rule for the use of radiography in acute ankle injury. N Z Med J (1994) 2.71
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet (2000) 2.69
Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen (2004) 2.62
Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature (1993) 2.57
Sunscreens, suntans, and skin cancer. BMJ (1996) 2.34
Mismatch correction at O6-methylguanine residues in E. coli DNA. Nature (1982) 2.33
Escherichia coli mutants deficient in 3-methyladenine-DNA glycosylase. J Mol Biol (1980) 2.32
The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol (1989) 2.27
Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol (2000) 2.03
Enzymatic excision of free hypoxanthine from polydeoxynucleotides and DNA containing deoxyinosine monophosphate residues. J Biol Chem (1978) 1.84
A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen (2004) 1.81
p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet (1998) 1.79
The results of tubal surgery in the treatment of infertility in two non-specialist hospitals. Br J Obstet Gynaecol (1990) 1.71
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant (2008) 1.65
DNA excision repair pathways. Curr Opin Genet Dev (1997) 1.64
DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res (1995) 1.64
Diversity in cell properties and transport behavior among 12 different environmental Escherichia coli isolates. J Environ Qual (2009) 1.63
Hypoxanthine in deoxyribonucleic acid: generation by heat-induced hydrolysis of adenine residues and release in free form by a deoxyribonucleic acid glycosylase from calf thymus. Biochemistry (1980) 1.59
Blue calls--time for a change? Emerg Med J (2001) 1.55
The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol (2002) 1.52
O6-Methylguanine-DNA methyltransferase of human lymphoid cells: structural and kinetic properties and absence in repair-deficient cells. Cancer Res (1983) 1.52
Site-specific mutagenesis in vivo by single methylated or deaminated purine bases. Mutat Res (1986) 1.51
Guidelines for the management of actinic keratoses. Br J Dermatol (2007) 1.49
Genetic steps in colorectal cancer. Nat Genet (1994) 1.48
Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol (1999) 1.46
cDNA cloning and chromosomal assignment of the human O6-methylguanine-DNA methyltransferase. cDNA expression in Escherichia coli and gene expression in human cells. J Biol Chem (1990) 1.43
DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage. Biochemistry (1994) 1.43
Phenytoin in pre-eclampsia. Lancet (1989) 1.40
Milia complicating successfully treated cutaneous leishmaniasis in three children. Br J Dermatol (2006) 1.39
Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucleic Acids Res (1997) 1.38
Noninvasive monitoring of adrenocortical activity in carnivores by fecal glucocorticoid analyses. Gen Comp Endocrinol (2004) 1.36
Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg (1994) 1.36
Surgical treatment of the spontaneous spinal epidural abscess. Surg Neurol (1992) 1.32
Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer (1992) 1.31
Repair of O-alkylpyrimidines in mammalian cells: a present consensus. Proc Natl Acad Sci U S A (1988) 1.30
Unmasking a killer: DNA O(6)-methylguanine and the cytotoxicity of methylating agents. Mutat Res (2000) 1.29
Mismatch repair and response to DNA-damaging antitumour therapies. Eur J Cancer (2003) 1.26
The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res (1996) 1.25
Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins. Nucleic Acids Res (1997) 1.22
A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer (2007) 1.20
Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol (2004) 1.20
Cervical spondylotic myelopathy: functional and radiographic long-term outcome after laminectomy and posterior fusion. Neurosurgery (1999) 1.19
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br J Cancer (2010) 1.19
DNA repair. Int Rev Cytol (1981) 1.17
Selective binding to DNA base pair mismatches by proteins from human cells. J Biol Chem (1989) 1.16
Mismatch repair defects and O6-methylguanine-DNA methyltransferase expression in acquired resistance to methylating agents in human cells. J Biol Chem (1997) 1.16
Processing in vitro of an abasic site reacted with methoxyamine: a new assay for the detection of abasic sites formed in vivo. Nucleic Acids Res (1991) 1.16
Complementation of sensitivity to alkylating agents in Escherichia coli and Chinese hamster ovary cells by expression of a cloned bacterial DNA repair gene. EMBO J (1986) 1.14
Somatic hypermutation of Ig genes in patients with xeroderma pigmentosum (XP-D). Int Immunol (1996) 1.14
A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant (2011) 1.13
DNA excision-repair deficiency of human peripheral blood lymphocytes treated with chemical carcinogens. Cancer Res (1976) 1.13
Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technol Assess (2011) 1.13
The learning curve in vestibular schwannoma surgery. Am J Otol (1999) 1.12
A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype. Proc Natl Acad Sci U S A (1994) 1.11
Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells. Oncogene (2000) 1.10
Screening for open neural-tube defects in England and Wales. Br Med J (1979) 1.09
Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol (1999) 1.09
The effect of magmatic activity on hydrothermal venting along the superfast-spreading East pacific rise. Science (1995) 1.08
Repair of depurinated DNA in vitro by enzymes purified from human lymphoblasts. Proc Natl Acad Sci U S A (1978) 1.08
Immune surveillance in colorectal carcinoma. Nat Genet (1995) 1.07
Novel mutations in the pheA gene of Escherichia coli K-12 which result in highly feedback inhibition-resistant variants of chorismate mutase/prephenate dehydratase. Appl Environ Microbiol (1992) 1.06
Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach. J Clin Pathol (1998) 1.06
Prevention of breast cancer in the context of a national breast screening programme. J Intern Med (2012) 1.05
A simple model for potential use with a misclassified binary outcome in epidemiology. J Epidemiol Community Health (2004) 1.04
Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. Cancer Res (2000) 1.04
Processing of O6-methylguanine by mismatch correction in human cell extracts. Curr Biol (1996) 1.04
Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol (1996) 1.03
A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant (2012) 1.02
Quantitative outcome and radiographic comparisons between laminectomy and laminotomy in the treatment of acquired lumbar stenosis. Neurosurgery (1997) 1.02
Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med (2000) 1.01
Photoactivation of DNA thiobases as a potential novel therapeutic option. Curr Biol (2001) 0.99
Why is it getting more difficult to successfully artificially inseminate dairy cows? Animal (2008) 0.99
Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. Trop Doct (2007) 0.99
An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol (2001) 0.99
All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. J Med Screen (2002) 0.98
Intervention debulking surgery in advanced epithelial ovarian cancer. Br J Obstet Gynaecol (1994) 0.97
Transudative malignant pleural effusions: prevalence and mechanisms. South Med J (1998) 0.97
hMSH2-independent DNA mismatch recognition by human proteins. J Biol Chem (1996) 0.97
Should menstruation be optional for women? Lancet (2000) 0.96
Specificity of the bacteriophage PBS2 induced inhibitor of uracil-DNA glycosylase. Biochemistry (1981) 0.95
How much to do at the accident scene? Paramedic agrees with most of comments about prehospital care. BMJ (2000) 0.95
Atypical pigmented lesions following extensive PUVA therapy. Clin Exp Dermatol (2000) 0.95
DNA replication arrest and tolerance to DNA methylation damage. Carcinogenesis (1994) 0.94
Isoniazid induced pellagra despite pyridoxine supplementation. Clin Exp Dermatol (1999) 0.94
A biochemical defect in the repair of alkylated DNA in cells from an immunodeficient patient (46BR). Carcinogenesis (1983) 0.93
The cytotoxic and mutagenic effects of alkylating agents on human lymphoid cells are caused by different DNA lesions. Carcinogenesis (1985) 0.93
Measuring performance in clinical breast examination. Br J Surg (2010) 0.92
Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol (2007) 0.91
Incision at DNA G.T mispairs by extracts of mammalian cells occurs preferentially at cytosine methylation sites and is not targeted by a separate G.T binding reaction. Biochemistry (1993) 0.91
Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series. Am J Transplant (2013) 0.91